UC Berkeley

Dr. Jennifer Doudna at UC Berkeley and the Innovative Genomics Institute (IGI) is the 2020 Nobel Prize Winner in Chemistry for co-inventing CRISPR-Cas genome editing technology.

Focus

CRISPR

Services

Public Relations

VISIT THE SITE

Challenge

How do you inform and engage the public in the profound ethical and societal implications of what has been hailed as the “scientific breakthrough of the century”?

Approach

Through a curated mix of high-reach, global media and speaking opportunities, we assist Dr. Doudna’s efforts to advance understanding of the relevance and potential of CRISPR-Cas genome editing technology – its applications, risks, and opportunities.

Impact

In October 2020, Dr. Doudna was awarded the Nobel Prize in Chemistry along with Dr. Emmanuelle Charpentier “for the development of a method for genome editing.”

Read the award press release here.

By deploying timely, transparent, and relatable messages, Dr. Doudna has enabled the public, lawmakers, and the business community to better understand CRISPR technology and how it can be responsibly used to positively impact humankind.

Her willingness to drive a holistic conversation through hundreds of media articles, broadcast interviews, opinion editorials, and live speaking events has helped a global audience see the benefits of fundamental research and anticipate new CRISPR-based human therapeutics, diagnostics, and agriculture products that can radically improve lives.

Her work to push the limits of the technology, strong patent position across 30 countries including the U.S., U.K, and China and optimistic vision for a better future is powering a rapidly growing CRISPR economy, creating hundreds of jobs at innovative companies focused on applying the technology in unique ways.

500⁺